56
Y.-H. Shi et al. / Fitoterapia 108 (2016) 55–61
Fisher Scientific, Inc., USA). IR spectra were measured by using a JASCO
FT/IR-460 Plus spectrophotometer (JASCO International Co. Ltd., Japan).
Optical rotations were detected by using a JASCO P2100 digital polarim-
eter (JASCO International Co. Ltd., Japan). Column chromatography (CC)
was performed with normal-phase (Wakogel® C-200 and 300HG, Wako
Pure Chemical Industries, Ltd., Japan), reverse-phase [ODS-A (12 nm, s-
150 μm) and ODS-AQ-HG (12 nm, s-50 μm), YMC Co., Ltd., Japan], and
Sephadex LH-20 (GE Healthcare Life Sciences, Sweden). Preparative
HPLC was performed on a Waters HPLC system (Waters Co. Ltd., USA)
equipped with a Delta 600 pump and 2489 UV detector by using
YMC-Pack ODS-A column (5 μm, 250 × 20 mm i.d.). TLC was carried
and 5 (33.0 mg) from 80MF-7-3, and 2 (2.0 mg) from 80MF-7-5
were also achieved on the preparative HPLC eluted with MeCN–H2O
(20:80, v/v).
2.3.1. Paeoniflorol (1)
White, amorphous powder; [α]2D0 −33.33° (c = 0.13, MeOH); IR
(KBr): νmax 3418, 1715, 1631, 1456, 1281, 1075, 712 cm−1 1H– and
;
13C NMR data are showed in Table 1; ESI-MS: m/z 511 [M + HCOO]−
;
,
HR-ESI-MS: m/z 511.1812 [M + HCOO]− (calcd. for C24H31O12
511.1816).
out to monitor fractions on precoated silica gel (60F254) or RP-18 (F254
)
2.3.2. 4′-hydroxypaeoniflorigenone (2)
plates (0.50 mm thickness, Merck, Germany). Spots were visualized
under UV (254 and 360 nm) and/or monitored by spraying with the
solution of 10% sulfuric acid in ethanol (v/v). L-cysteine methyl ester
hydrochloride, phenyl isothiocyanate, L-(−)-glucose (purity: ≥98%),
White, amorphous powder; [α]2D0 +4.99° (c = 0.10, MeOH); IR
(KBr): νmax 3402, 1712, 1609, 1514 cm−1 1H– and 13C NMR data are
;
given in Table 1; ESI-MS: m/z 335 [M + H]+; HR-ESI-MS: m/z
335.1124 [M + H]+ (calcd. for C17H19O7, 335.1124).
D-(+)-glucose (purity: ≥98%), and pyridine were purchased from Wako
Pure Chemical Industries, Ltd.
2.3.3. 4-epi-albiflorin (3)
White, amorphous powder; [α]2D0 −21.40° (c = 0.11, MeOH); IR
(KBr): νmax 3389, 1755, 1715, 1631, 1452, 1280, 1075, 715 cm−1; 1H–
and 13C NMR data are given in Table 1; ESI-MS: m/z 525
[M + HCOO]−; HR-ESI-MS: m/z 525.1617 [M + HCOO]− (calcd. for
2.2. Plant material
Red peony root was purchased from Chifeng Rongxintang Pharma-
ceutical Co. Ltd., Inner Mongolia autonomous region, China, in Oct.
2013, which was clearly identified as RPR type of P. lactiflora by genetic
analysis of nrDNA ITS sequence [4]. The voucher (TMPW No. 27967) is
deposited in the Museum of Materia Medica, Institute of Natural
Medicine (TMPW), University of Toyama, Japan.
C24H29O13, 525.1608).
2.4. Acid hydrolysis and sugar analysis of compounds 1 and 3
Acid hydrolysis of 1 and 3 was carried out using a procedure similar
to previous report [15]. Briefly, compounds 1 and 3 (1.0 mg, respective-
ly) were hydrolyzed by heating in 1.0 M HCl (0.2 ml) at 90 °C for 2 h and
then neutralized with Amberlite IRA400. After drying in vacuo, the res-
idue was dissolved in pyridine (0.1 ml) containing L-cysteine methyl
ester hydrochloride (0.5 mg) and heated at 60 °C for 1 h, and then
0.1 ml solution of phenyl isothiocyanate (0.5 mg) was added to the
mixture and heated at 60 °C for 1 h. The reaction solution was directly
analyzed by HPLC-PDA system to determine the D/L configuration of
sugar moieties by comparing their retention time (tR) with the
authentic D- and L-glucose derivatives (tR: D-glucose, 18.03 min; L-
glucose, 17.02 min).
2.3. Extraction and isolation
The dried roots (1.5 kg) were cut into small pieces and then extract-
ed repeatedly with methanol (3 × 2.5 L) by ultrasonic for 2 h at room
temperature. The MeOH-extract (280.0 g) was obtained after removing
the solvent under vacuum, and then was subjected to Daion HP 21 CC
eluted with a gradient of H2O and MeOH as 0, 20%, 40%, 60%, 80% and
100% MeOH (v/v), respectively. The anti-allergic activity assay showed
that the 60% and 80% aqueous MeOH-elutions had significant inhibitory
activities against β-hexosaminidase release in IgE-sensitized RBL-2H3
cells, so the two elutions were further isolated for tracking the active
constituents. The 60% MeOH-elution (30.8 g) was suspended in water
and partitioned with EtOAc and n-BuOH, respectively. The n-BuOH-
soluble fraction was then subjected to YMC-ODS-A CC eluted with
MeOH–H2O (1:9 to 1:0, v/v) to obtain six fractions (60MBF-1 to 6).
The 60MBF-2 was further subjected to YMC-ODS AQ CC eluted with
MeOH–H2O (1:9 to 1:0, v/v) to give seven fractions (60MBF-2-1 to 7).
60MBF-2-3 was separated by preparative HPLC eluted with isocratic
acetonitrile(MeCN)-H2O (15:85, v/v) to give 1 (6.0 mg) and 8
(5.0 mg). Compound 11 (20.0 mg) was obtained from 60MBF-2-4 by
using sephadex LH-20 CC with MeOH–H2O (6:4, v/v). The 60MBF-3
was separated by YMC-ODS-A CC eluted with MeOH–H2O (1:1, v/v) to
give four fractions (60MBF-3-1 to 4). Compounds 7 (5.0 mg) and 12
(3.0 mg) were purified from 60MBF-3-1 by using preparative HPLC
with isocratic elution of MeCN–H2O (15:85, v/v). The 60MBF-3-2 was
further separated by sephadex LH-20 CC eluted with MeOH–H2O (6:4,
v/v) to give 15 (2.0 mg). In addition, 80% MeOH-elution (5.9 g) was sub-
jected to a normal phase silica gel CC eluted by CH3Cl–MeOH with gra-
dient condition from 1:0 to 1:5 (v/v) to give seven fractions (80MF-1 to
7). The 80MF-1 was purified by the preparative HPLC with MeCN–H2O
(30:70, v/v) to give 4 (10.0 mg) and 6 (18.0 mg). Compounds 9
(100.0 mg) and 16 (10.0 mg) were purified from 80MF-3 under the
same pre-HPLC condition. The 80MF-7 was further separated by
sephadex LH-20 CC with MeOH–H2O (6:4, v/v) to give five subfractions
(80MF-7-1 to 5). The isolation of 14 (33.0 mg) from 80MF-7-2, 10
(50.0 mg) and 13 (40.0 mg) from 80MF-7-4 were achieved by using pre-
parative HPLC with MeCN–H2O (30:70, v/v). The isolation of 3 (8.0 mg)
2.5. Inhibitory effects on the release of β-hexosaminidase from RBL-2H3
cells
The inhibitory effects of the test samples against 2, 4-
dinitrophenylated bovine serum albumin (DNP-BSA) stimulated β-
hexosaminidase release in IgE-sensitized RBL-2H3 cells (Cell No.
RCB2782, RIKEN Cell Bank, Tsukuba, Japan) were evaluated by a previ-
ously reported method [16,18]. Briefly, RBL-2H3 cells were dispended
into 96-well culture plates at a concentration of 4 × 105 cells/well
using Eagle's Minimum Essential Medium (MEM, Gibco, Thermo Fisher
Scientific Inc., USA) supplementing with 10% Fetal Bovine Serum (FBS,
12003C, Sigma-Aldrich Co. LLC., USA), penicillin (100 U/ml, Sigma-
Aldrich) and streptomycin (100 μg/ml, Sigma-Aldrich) and cultured
overnight at 37 °C in 5% CO2. After washing with phosphate-buffered sa-
line (PBS, Gibco), the cells were sensitized with 0.5 μg/ml of anti-DNP
IgE (D8406, Sigma-Aldrich) for 24 h, and then washed twice with
200 μl Siraganian buffer [119 mM NaCl, 5 mM KCl, 0.4 mM MgCl2,
25 mM piperazine-N,N’-bis (2-ethanesulfonic acid) (PIPES), 40 mM
NaOH; pH 7.2] and incubated in 160 μl Siraganian (+) buffer [Added
5.6 mM glucose, 1 mM CaCl2 and 0.1% bovine serum albumin (BSA,
A7030, Sigma-Aldrich Co. LLC., USA) in Siraganian buffer; pH 7.2] for
10 min at 37 °C. Subsequently, 50 μl of test sample solution was added
to each well and incubated for 30 min, followed by adding 50 μl DNP-
BSA (1.0 μg/ml, A23018, Thermo Fisher Scientific Inc.) as an antigen
for 1 h to stimulate cells and to evoke allergic reactions (degranulation).
The reaction was stopped by cooling in an ice-bath for 10 min, and then
100 μl of the supernatant was transferred to a new 96-well plate and